Sudden death of COVID-19 patients in Wuhan, China: A retrospective cohort study

Nan Yang1, Kunming Tian2, Meng Jin3

  • 1Department of Epidemiology and Biostatistics, Key Laboratory for Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, China.

Insights

Sudden death in COVID-19 patients, often linked to severe inflammation and organ dysfunction, particularly affecting the liver and heart, warrants further investigation. Understanding these risk factors is crucial for patient outcomes.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Critical Care

Background:

  • The emergence of coronavirus disease 2019 (COVID-19) in late 2019 led to a significant global health crisis.
  • COVID-19 caused approximately 4000 deaths in China alone during the initial outbreak.
  • Characterizing clinical features and identifying risk factors for sudden death in COVID-19 patients is essential.

Purpose of the Study:

  • To systematically analyze the clinical characteristics of deceased COVID-19 patients.
  • To determine the risk factors associated with sudden death among COVID-19 fatalities.
  • To compare clinical features between sudden and non-sudden death groups in COVID-19.

Main Methods:

  • A retrospective study of 281 deceased COVID-19 patients admitted to Tongji hospital between January 22 and March 23, 2020.
  • Patients were categorized into sudden death (died within 24 hours of admission) and non-sudden death groups.
  • Logistic regression analysis was employed to identify risk factors for sudden death.

Main Results:

  • Sudden death occurred in 10% of the deceased patients (28 out of 281).
  • Sudden deaths showed higher fatigue incidence, lower eosinophil counts, and elevated levels of inflammatory markers (procalcitonin, CRP) and organ function indicators (ALT, AST, LDH, BNP).
  • No significant differences were observed in gender, age, chest CT findings, or comorbidities between the groups.

Conclusions:

  • Sudden death in COVID-19 patients is associated with more severe systemic inflammation and multi-organ dysfunction, particularly impacting liver and heart function.
  • These findings highlight distinct clinical profiles in sudden COVID-19 fatalities.
  • Further research is recommended to validate these observations and elucidate underlying mechanisms.
Abstract

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.2K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
615
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
522
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
453
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
925
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
270